A PET (Positron Emission Tomography) scan is a diagnostic imaging tool that produces pictures of any abnormal cell activity in the body, often before changes may be visible on conventional imaging. A tiny amount of a radioactive substance, called a radionuclide (radiopharmaceutical or radioactive tracer), is used during the procedure to assist in the examination of the tissue under study.
PET scans can detect cancers, brain disorders such as Alzheimer’s Disease, Parkinson’s Disease and epilepsy, heart disease and bone abnormalities.
CT (Computed Tomography) uses a combination of x-rays and high-powered computers to obtain cross-sectional images of the body.
The combination of PET and CT produces a highly sensitive imaging device able to detect early stages of disease often undetectable by CT alone or by other imaging procedures such as MRI.
PET CT scans are simple and painless, offering patients and their families information that helps doctors detect and diagnose disease early and begin treatment quickly. It can also provide much more specific information, distinguishing between benign and malignant disorders for example, unlike other medical imaging techniques such as ultrasound, x-rays, MRI or CT that merely confirm the presence of a mass.
PET CT can also help doctors monitor the treatment of disease. For example, chemotherapy leads to changes in cellular activity and these changes can be seen on PET CT scans long before any structural changes can be measured by other imaging techniques. These scans give doctors another tool to evaluate treatments, perhaps even leading to a modification in treatment before any other imaging is done.